Finding Answers in Prostate Cancer
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
The FDA has approved enzalutamide for non-metastatic prostate cancer that is sensitive to antiandrogen therapy. The U.S. Food and Drug Administration (FDA) has approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-sensitive prostate cancer...
Lorazepam used to relieve stress may cause inflammation that promotes tumor growth and shortens progression-free survival, study says. A medication commonly used to ease the stress caused by cancer diagnosis and treatment may be...
The FDA approved the PARP inhibitor talazoparib in combination with hormone therapy for metastatic prostate cancer The U.S. Food and Drug Administration (FDA) has approved talazoparib (Talzenna) in combination with the antiandrogen therapy enzalutamide...
The FDA approved the DNA damage repair inhibitor olaparib, in combination with other therapies, for Castration-resistant or refractory prostate cancer The U.S. Food and Drug Administration (FDA) has approved olaparib (Lynparza), in combination with...
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
The FDA has approved a radioactive compound and companion diagnostic test for patients with advanced prostate cancer. The U.S. Food and Drug Administration (FDA) has approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto) for adult...
A new program specializes in concerns of gay and bisexual men with prostate cancer, and other cancer research news of the week.
African American men are more likely to feel regret about prostate cancer treatment decisions, and more news of the week from Cancer Today.
The FDA approved the first once-a-day pill to lower the levels of testosterone in certain patients with prostate cancer. The U.S. Food and Drug Administration (FDA) has approved the first oral gonadotropin-releasing hormone (GnRH)...